Immunocompromised patients have been neglected in COVID-19 trials: a call for action-Reference-Cited by-同舟云学术

Immunocompromised patients have been neglected in COVID-19 trials: a call for action

Published:2022-09 Issue:9 Volume:28 Page:1182-1183
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Trøseid Marius,Hentzien Maxime,Ader Florence,Cardoso Sandra Wagner,Arribas Jose R.,Molina Jean-Michel,Mueller Nicolas,Hites Maya,Bonnet Fabrice,Manuel Oriol,Costagliola Dominique,Grinsztejn Beatriz,Olsen Inge Christoffer,Yazdapanah Yazdan,Calmy Alexandra

Funder

Horizon 2020

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference9 articles.

1. Patients with CLL have similar high risk of death upon the omicron variant of COVID-19 as previously during the pandemic;Nieman;medRxiv,2022

2. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report;Gandhi;Nat Commun,2022

3. SARS-CoV-2 evolution during treatment of chronic infection;Kemp;Nature,2021

4. Early remdesivir to prevent progression to severe Covid-19 in outpatients;Gottlieb;N Engl J Med,2022

5. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19;Hammond;N Eng J Med,2022

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in the immunocompromised host;COVID-19: An Update;2024-09-01

2. Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection;Journal of Virology;2024-08-29

3. Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement;Scientific Reports;2024-07-23

4. How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients;Transplant Infectious Disease;2024-07-05

5. Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023);Frontiers in Immunology;2024-06-27